Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and High-Dose Cytarabine in R/R AML or ALL
NCT01656031Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2005
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Wake Forest University Health Sciences. Started Feb 2005; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01656031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656031.